1/ 🚨New research alert! 🚨Our study in @BloodCancerJnl shows that high WEE1 expression is an independent predictor of poor survival in multiple myeloma (MM), with @RossFirestone, @MalinHultcrantz, @LarryNortonMD, @szusmani, and the rest of the @MSKCancerCenter team! 🧵👇

New paper with @RossFirestone @szusmani @TAkhlagh @UrviShahMD @FrancescoMaura4 @MalinHultcrantz and the rest of the wonderful MSK team!

6/Computational/AI PA-205 (Zang) MMRF CoMMpass Explorer PA-366 (Simhal) CALM to predict SMM progression PA-391 (Ntanasis-Stathopoulos) RW validation of new IMS/IMWG HR Criteria PA-477 (Flores Pérez) HealthTree Heal-MM #IMS25 #mmsm @Myeloma_Society @SocietyofHemOnc

#Myeloma Paper of the Day: Immune-MRD status informs tumor-MRD outcome prognostication in myeloma pts on Len maintenance; T cell profiles enriched w/ activated cytotoxic effectors predict early relapse & quiescent/naïve T-cells predicting remission: pubmed.ncbi.nlm.nih.gov/4085…. #mmsm

#Lungcancer can co-opt genes that normally help a fetus develop and evade the mother’s immune system, according to research from Dr. Jung Hun Oh, an associate attending computer scientist in MSK’s Department of Medical Physics, and colleagues. And while these pregnancy-specific glycoproteins (PSGs) can get activated in the cancers of both men and women, female patients had poorer outcomes. The analysis suggests targeting these genes might improve survival in female patients with lung cancer. Learn more about Dr. Oh's research: bit.ly/4kLUZsb

90% of doing science is being open to new ideas.

Myeloma Paper of the Day, February 22nd, suggested by @Myeloma_Doc @RossFirestone oncodaily.com/science/myelom… #Myeloma #Cancer #OncoDaily #Medicine #Oncology #Health #MedEd #MedX #MedNews

#Myeloma Paper of the Day: WEE1 expression is prognostic independent of known biomarkers, differentiates outcomes associated w/ known markers, is upregulated independently of its interacting neighbors, & is associated w/ dysregulated P53 pathways: pubmed.ncbi.nlm.nih.gov/3997…. #mmsm